HomeCategoryMedical - Verséa

https://i0.wp.com/www.versea.com/wp-content/uploads/2022/09/2202092_Versea-Easy-Lab-24ct-Half-Sidekick-Counter-Display.png?resize=844%2C640&ssl=1

At this year’s NACS Show 2022 Verséa Holdings, Inc. is launching their new business division Verséa Health and their Product Line Portfolio Verséa Easy Lab™. James Olin, Chief Commercial Officer at Verséa, explains the reason behind the launch: “Verséa Health was created with a mission to give millions of Americans direct-access to the most essential...

https://i0.wp.com/www.versea.com/wp-content/uploads/2022/03/vision-concept_800-e1648064890754.jpg?resize=800%2C464&ssl=1

A recently published peer-reviewed scientific article “Cannabinol Modulates Neuroprotection and Intraocular Pressure: A Potential Multi-Target Therapeutic Intervention for Glaucoma” has provided insight into unique therapeutic potential of Cannabinol (CBN) for glaucoma treatment   The article, published in a leading international journal Biochimica et Biophysical Acta (BBA – Molecular Basis of Disease) (LINK to the article)...

Collaboratively administrate turnkey channels whereas virtual e-tailers. Objectively seize scalable metrics whereas proactive e-services. Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI.